Upregulation of CCR7 by tumour‐resident cDC1s and cDC2s can be accompanied by shared heterogeneous transcriptional activation programmes that are associated with the activation or suppression of T cell effector function [44, 45]. Here, CCR7 is linked to neoplasm.